PT102642A - PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE - Google Patents
PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINEInfo
- Publication number
- PT102642A PT102642A PT102642A PT10264201A PT102642A PT 102642 A PT102642 A PT 102642A PT 102642 A PT102642 A PT 102642A PT 10264201 A PT10264201 A PT 10264201A PT 102642 A PT102642 A PT 102642A
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical
- dosage containing
- pharmaceutical composition
- unique dosage
- containing brivudine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI000009A ITMI20010009A1 (en) | 2001-01-03 | 2001-01-03 | PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT102642A true PT102642A (en) | 2002-07-31 |
| PT102642B PT102642B (en) | 2003-06-30 |
Family
ID=11446384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT102642A PT102642B (en) | 2001-01-03 | 2001-07-05 | PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE |
Country Status (20)
| Country | Link |
|---|---|
| AT (1) | AT6141U1 (en) |
| BE (1) | BE1014522A5 (en) |
| CH (1) | CH695662A5 (en) |
| CZ (1) | CZ20012464A3 (en) |
| DK (1) | DK177084B1 (en) |
| ES (1) | ES2192456B1 (en) |
| FI (1) | FI20011446A (en) |
| FR (1) | FR2818907B1 (en) |
| GB (1) | GB2370771A (en) |
| GR (1) | GR1004012B (en) |
| HR (1) | HRPK20010345B3 (en) |
| HU (1) | HUP0102816A3 (en) |
| IE (1) | IE20010413A1 (en) |
| IT (1) | ITMI20010009A1 (en) |
| NL (1) | NL1018431C2 (en) |
| PL (1) | PL348480A1 (en) |
| PT (1) | PT102642B (en) |
| SE (1) | SE0102309L (en) |
| SK (1) | SK287043B6 (en) |
| UA (1) | UA76402C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2239527B1 (en) * | 2004-03-01 | 2006-11-16 | M. Cruz Fernandez Gonzalez | PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER. |
| CN113712928A (en) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | Brivudine drug absorbed through oral mucosa |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0104857A1 (en) * | 1982-09-28 | 1984-04-04 | Beecham Group Plc | Deoxyuridine compounds, methods for preparing them and their use in medicine |
| IT1170232B (en) * | 1983-10-31 | 1987-06-03 | Anna Gioia Stendardi | THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY |
| US5446031A (en) * | 1991-04-24 | 1995-08-29 | Yamasa Shuyu Kabushiki Kaisha | 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives |
| DK0874631T3 (en) * | 1996-01-19 | 2004-03-22 | Glaxo Group Ltd | Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes in a single daily application |
-
2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/en unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/en not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/en not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/en not_active Application Discontinuation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/en not_active Expired - Lifetime
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/en not_active IP Right Cessation
- 2001-07-02 NL NL1018431A patent/NL1018431C2/en not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A/en not_active Application Discontinuation
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/en not_active IP Right Cessation
- 2001-07-04 SK SK957-2001A patent/SK287043B6/en not_active IP Right Cessation
- 2001-07-04 UA UA2001074658A patent/UA76402C2/en unknown
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/en unknown
- 2001-07-05 ES ES200101566A patent/ES2192456B1/en not_active Expired - Fee Related
- 2001-07-05 PT PT102642A patent/PT102642B/en active IP Right Grant
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/en unknown
- 2001-07-05 GR GR20010100322A patent/GR1004012B/en unknown
- 2001-07-05 PL PL01348480A patent/PL348480A1/en not_active Application Discontinuation
-
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE0102309D0 (en) | 2001-06-28 |
| SK9572001A3 (en) | 2003-03-04 |
| BE1014522A5 (en) | 2003-12-02 |
| HRPK20010345B3 (en) | 2005-02-28 |
| GR1004012B (en) | 2002-11-01 |
| ITMI20010009A0 (en) | 2001-01-03 |
| HU0102816D0 (en) | 2001-09-28 |
| GR20010100322A (en) | 2002-10-08 |
| GB0110682D0 (en) | 2001-06-20 |
| AT6141U1 (en) | 2003-05-26 |
| PT102642B (en) | 2003-06-30 |
| SE0102309L (en) | 2002-07-04 |
| GB2370771A (en) | 2002-07-10 |
| FI20011446A0 (en) | 2001-07-03 |
| PL348480A1 (en) | 2002-07-15 |
| CH695662A5 (en) | 2006-07-31 |
| IE20010413A1 (en) | 2003-04-16 |
| HUP0102816A2 (en) | 2002-10-28 |
| HRP20010345A2 (en) | 2003-08-31 |
| FI20011446A (en) | 2002-07-04 |
| HUP0102816A3 (en) | 2005-01-28 |
| FR2818907A1 (en) | 2002-07-05 |
| DK200101019A (en) | 2002-07-04 |
| SK287043B6 (en) | 2009-10-07 |
| NL1018431C2 (en) | 2002-07-05 |
| DK177084B1 (en) | 2011-07-11 |
| ES2192456A1 (en) | 2003-10-01 |
| ITMI20010009A1 (en) | 2002-07-03 |
| UA76402C2 (en) | 2006-08-15 |
| CZ20012464A3 (en) | 2002-08-14 |
| FR2818907B1 (en) | 2006-05-26 |
| ES2192456B1 (en) | 2005-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE296619T1 (en) | SOLID ORAL DOSAGE FORM OF SIMETHICON | |
| PT1066027E (en) | PHARMACEUTICAL COMPOSITION OF TOPIRAMATO | |
| FI20011478A (en) | Pharmaceutical composition | |
| IS6986A (en) | Liquid pharmaceutical composition | |
| PL367180A1 (en) | Stabilized oral pharmaceutical composition | |
| HRP20030873A2 (en) | Pharmaceutical dosage form of amorphous nelfinavirmesylatoe having such element | |
| EE200200486A (en) | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and processes for their preparation | |
| DK1674084T3 (en) | Prolonged release of oral dosage composition | |
| EE05020B1 (en) | The pharmaceutical composition of G1buride | |
| DK1458377T3 (en) | Pharmaceutical compositions containing tegaserod | |
| BRPI0209720A2 (en) | dosage and packaging of controlled release medication | |
| IS7051A (en) | pharmaceutical compositions | |
| DK1425005T3 (en) | Pharmaceutical composition containing lumiracoxib | |
| FI20022128A0 (en) | Pharmaceutical composition | |
| PT1558263E (en) | PROLONGED LIBERATION PHARMACEUTICAL COMPOSITION | |
| ATE350016T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID | |
| EE200300468A (en) | Stable pharmaceutical composition of pravastatin | |
| PT1227817E (en) | AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING | |
| LU90483B1 (en) | New compositions of parox-tine m-thanesulfonate | |
| HUP0401862A3 (en) | Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them | |
| PT102642A (en) | PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE | |
| ITBO20010005V0 (en) | AUTOMATIC DISPENSER OF MEDICINAL PRODUCTS | |
| ATE350029T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN | |
| NO20033073L (en) | Pharmaceutical composition containing citalopram | |
| ITMI20011284A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERPHOSPHATEMIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 20030514 |